Published in Cancer Weekly, December 17th, 2002
They suggest a "plausible role of neoangiogenesis, as a central theme in the development of MUPs..."
According to K.N. Naresh and colleagues, Tata Memorial Hospital, Maharashtra, "Invasive cancers, which cannot or do not switch to the angiogenic phenotype, remain subclinical. In situations where a nonangiogenic tumor attempts to grow beyond the volume that can be supported by the vasculature, marked apoptosis and cell turnover result. Tumors with a high cell turnover are biologically advanced. Thus, such subclinical tumors acquire a metastatic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.